Blog Post
We’re at SLEEP 2023 in Indianapolis
Amy Kant (our Transition Director) is attending the AASM SLEEP Conference in Indianapolis this week, with board members John Ensminger and Keith Harper. On Monday, Amy gave […]
Register Today for “Narcolepsy Gut Check” on March 1st
January is Mental Wellness Month
What is mental wellness? According to the World Health Organization, mental wellness is “a state of well-being in which the individual realizes his or her own abilities, can cope […]
10 ways to manage stress this winter
With shorter periods of daylight and cold weather, winter can make living with narcolepsy, idiopathic hypersomnia, and related health issues even more challenging. This is why getting […]
Stay Hydrated This Summer
While exposure to light is supposed to promote “alertness”, it’s not uncommon to feel tired or even sluggish after spending time outside. There are many factors that […]
Listening Journey: Our Collective Voice Matters
Last year, Narcolepsy Network began a “Listening Journey” to better understand our organization’s individual and collective interests. We also sought out the perspectives of medical professionals and industry […]
Clinical Research Matters: Takeaways From World Sleep Congress 2022
by Keith Harper, Board President Last week, Amy Kant, Transition Director, and I traveled to Rome for the 2022 World Sleep Congress, an event put together by […]
ROME: World Sleep 2022
We are excited to announce that we will be attending World Sleep 2022, in Rome, Italy, from March 14-16. The World Sleep congress, now in its 16th iteration, […]
Narcolepsy Advocacy Program Workshop
Our first virtual Narcolepsy Advocacy Program Workshop was a huge success, training more than 30 youth and young adults. Narcolepsy Network will be hosting additional workshops throughout […]
Avadel Pharmaceuticals Announces Results from its Phase 3 Trial of Once-Nightly FT218
Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced positive topline data from its pivotal Phase 3 REST-ON trial assessing the safety and efficacy of FT218, an investigational, once-nightly formulation […]
